Clinical trial
Epoetin Alfa for Anemia in Patients With Cancer Receiving Non-platinum…
NCT00270127 · Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Industry · Completed
Key facts
| NCT number | NCT00270127 |
|---|---|
| Title | Epoetin Alfa for Anemia in Patients With Cancer Receiving Non-platinum Chemotherapy |
| Official title | Double-Blind, Placebo-Controlled Study to Assess the Effect of Early Intervention and/or Treatment With Epoetin Alfa on Anemia in Cancer Patients Receiving Non-Platinum-Containing Chemotherapy |
| Lead sponsor | Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Anemia, Cancer, Neoplasm |
| Intervention type | Drug |
| Interventions | Epoetin alfa |
| Enrollment | 375 |
| Start date | Aug 1, 1996 |
| Completion | Sep 1, 1998 |
| First posted | Dec 26, 2005 |
| Last update posted | May 18, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: